Please login to the form below

Not currently logged in
Email:
Password:

Optum

This page shows the latest Optum news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Andrew Witty's replacement on Accelerated Access initiative, Blincyto gains full EU approval and more

Daily Brief: Andrew Witty's replacement on Accelerated Access initiative, Blincyto gains full EU approval and more

stalled. The ex-pharma leader gave up the position to avoid any potential conflict of interest after accepting the CEO role at healthcare services firm Optum in March.

Latest news

  • Health insurers will test blockchain for data handling Health insurers will test blockchain for data handling

    The healthcare payers - Humana, UnitedHealthcare and Optum - have joined forces with lab testing firm Quest Diagnostics and cost-management specialist MultiPlan to pilot the use of blockchain to “improve data quality

  • Amazon's healthcare move takes aim at US costs Amazon's healthcare move takes aim at US costs

    UnitedHealth, the biggest health insurer in the US, saw its stock fall 7.1% and its recently acquired health services unit Optum was also down 5%.

  • Sanofi sets up diabetes joint venture with Google's Verily Sanofi sets up diabetes joint venture with Google's Verily

    Onduo is being headed up by Joshua Riff, a medic by training who has previously held senior roles at health services company Optum, part of United Healthcare, and the Target group.

  • Mobile health roundup

    Optum has launched a ' health care cloud' service that aims to help healthcare professionals communicate with each other and their patients through secure text and video chat. ... By providing a secure place where more people can contribute to the

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics